Muhammad Baghdadi

2.1k total citations · 1 hit paper
32 papers, 1.7k citations indexed

About

Muhammad Baghdadi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Muhammad Baghdadi has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 12 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Muhammad Baghdadi's work include Immune cells in cancer (11 papers), Immune Cell Function and Interaction (9 papers) and Immunotherapy and Immune Responses (9 papers). Muhammad Baghdadi is often cited by papers focused on Immune cells in cancer (11 papers), Immune Cell Function and Interaction (9 papers) and Immunotherapy and Immune Responses (9 papers). Muhammad Baghdadi collaborates with scholars based in Japan, United States and Nigeria. Muhammad Baghdadi's co-authors include Masahisa Jinushi, Hironori Yoshiyama, Hirotoshi Dosaka‐Akita, Haruka Wada, Ken‐ichiro Seino, Ichiro Kinoshita, Shigeki Chiba, Hideo Yagita∥, Hisaya Akiba and Akinori Takaoka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Immunity.

In The Last Decade

Muhammad Baghdadi

32 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

2012 669 citations Shigeki Chiba, Muhammad Baghdadi et al. Nature Immunology profile →

Peers

Countries citing papers authored by Muhammad Baghdadi

Since Specialization

Citations

This map shows the geographic impact of Muhammad Baghdadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Baghdadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Baghdadi more than expected).

Fields of papers citing papers by Muhammad Baghdadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Baghdadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Baghdadi. The network helps show where Muhammad Baghdadi may publish in the future.

Co-authorship network of co-authors of Muhammad Baghdadi

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Baghdadi. A scholar is included among the top collaborators of Muhammad Baghdadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Baghdadi. Muhammad Baghdadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Induction of macrophage-like immunosuppressive cells from common marmoset ES cells by stepwise differentiation with DZNep 2020 ·Scientific Reports ·(unknown), Ryo Otsuka, Haruka Wada, (unknown), (unknown), (unknown), Muhammad Baghdadi, Erika Sasaki, Ken‐ichiro Seino	3
2	Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells 2020 ·Inflammation and Regeneration ·(unknown), (unknown), Naoki Hama, (unknown), (unknown), Hidehisa Takahashi, Haruka Wada, Ryo Otsuka, Muhammad Baghdadi, K. Seino	6
3	Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade 2020 ·iScience ·Naoki Hama, (unknown), (unknown), (unknown), (unknown), Ryo Otsuka, Haruka Wada, Heekyung Lee, Hwanseok Rhee, Yoshinori Hasegawa, Hideo Yagita∥, Muhammad Baghdadi, Ken‐ichiro Seino	19
4	Efficient generation of thymic epithelium from induced pluripotent stem cells that prolongs allograft survival 2020 ·Scientific Reports ·Ryo Otsuka, Haruka Wada, (unknown), (unknown), (unknown), (unknown), Muhammad Baghdadi, Ken‐ichiro Seino	29
5	Flow cytometric identification and cell-line establishment of macrophages in naked mole-rats 2019 ·Scientific Reports ·Haruka Wada, Yuhei Shibata, (unknown), Ryo Otsuka, (unknown), Yoshimi Kawamura, Kaori Oka, Muhammad Baghdadi, Tatsuya Atsumi, Kyoko Miura, Ken‐ichiro Seino	11
6	Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma 2018 ·Inflammation and Regeneration ·(unknown), Muhammad Baghdadi, (unknown), (unknown), (unknown), Haruka Wada, Keisuke Imafuku, Hiroo Hata, Ken‐ichiro Seino	34
7	Interleukin 34, from pathogenesis to clinical applications 2017 ·Cytokine ·Muhammad Baghdadi, (unknown), Y. Tanaka, Haruka Wada, Ken‐ichiro Seino	55
8	Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells 2016 ·Cancer Research ·Muhammad Baghdadi, Haruka Wada, Sayaka Nakanishi, (unknown), (unknown), Wira Eka Putra, Daisuke Endo, Hidemichi Watari, Noriaki Sakuragi, Yasuhiro Hida, Kichizo Kaga, Yohei Miyagi, Tomoyuki Yokose, Atsushi Takano, Yataro Daigo, Ken‐ichiro Seino	149
9	Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production iniNKT cells 2016 ·Proceedings of the National Academy of Sciences ·Masatoshi Kanda, Hiroyuki Yamanaka, Satoshi Kojo, (unknown), Hiroaki Honda, Yusuke Sotomaru, Michishige Harada, Masaru Taniguchi, Nao Suzuki, Tatsuya Atsumi, Haruka Wada, Muhammad Baghdadi, K. Seino	33
10	Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer 2015 ·Cancer Research ·(unknown), Muhammad Baghdadi, Takahiro Tsuchikawa, Haruka Wada, Toru Nakamura, (unknown), Sayaka Nakanishi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Toshiaki Shichinohe, Ken‐ichiro Seino, Satoshi Hirano	115
11	New immune regulation strategy in the age of regenerative medicine using pluripotent stem cells 2015 ·Inflammation and Regeneration ·Haruka Wada, (unknown), Hajime Sasaki, Muhammad Baghdadi, (unknown)	2
12	Cancer Stem-like Cells Derived from Chemoresistant Tumors Have a Unique Capacity to Prime Tumorigenic Myeloid Cells 2014 ·Cancer Research ·(unknown), Muhammad Baghdadi, Akihiro Yoneda, Ichiro Kinoshita, Shinya Suzu, Hirotoshi Dosaka‐Akita, Masahisa Jinushi	61
13	Induction of Macrophage-Like Immunosuppressive Cells from Mouse ES Cells That Contribute to Prolong Allogeneic Graft Survival 2014 ·PLoS ONE ·(unknown), Haruka Wada, Hajime Sasaki, (unknown), Ryo Otsuka, Muhammad Baghdadi, Satoshi Kojo, Tatsuya Chikaraishi, K. Seino	11
14	Blocking monoclonal antibodies of TIM proteins as orchestrators of anti-tumor immune response 2014 ·mAbs ·Muhammad Baghdadi, (unknown), Haruka Wada, Ken‐ichiro Seino	4
15	The impact of the TIM gene family on tumor immunity and immunosuppression 2013 ·Cellular and Molecular Immunology ·Muhammad Baghdadi, Masahisa Jinushi	25
16	TIM-4 Glycoprotein-Mediated Degradation of Dying Tumor Cells by Autophagy Leads to Reduced Antigen Presentation and Increased Immune Tolerance 2013 ·Immunity ·Muhammad Baghdadi, Akihiro Yoneda, (unknown), H. Nagao, Yoshihiro Komohara, Shigenori Nagai, Hisaya Akiba, Marc Foretz, Hironori Yoshiyama, Ichiro Kinoshita, Hirotoshi Dosaka‐Akita, Motohiro Takeya, Benoı̂t Viollet, Hideo Yagita∥, Masahisa Jinushi	104
17	MFG-E8 Regulates the Immunogenic Potential of Dendritic Cells Primed with Necrotic Cell-Mediated Inflammatory Signals 2012 ·PLoS ONE ·Muhammad Baghdadi, Shigeki Chiba, (unknown), Hironori Yoshiyama, Masahisa Jinushi	18
18	Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 breakdown → 2012 ·Nature Immunology ·Shigeki Chiba, Muhammad Baghdadi, Hisaya Akiba, Hironori Yoshiyama, Ichiro Kinoshita, Hirotoshi Dosaka‐Akita, Yoichiro Fujioka, Yusuke Ohba, Jacob V. Gorman, John Colgan, Mitsuomi Hirashima, Toshimitsu Uede, Akinori Takaoka, Hideo Yagita∥, Masahisa Jinushi	669
19	Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas 2012 ·Cancer Immunology Immunotherapy ·Muhammad Baghdadi, H. Nagao, Hironori Yoshiyama, Hisaya Akiba, Hideo Yagita∥, Hirotoshi Dosaka‐Akita, Masahisa Jinushi	44
20	ATM-Mediated DNA Damage Signals Mediate Immune Escape through Integrin-αvβ3–Dependent Mechanisms 2011 ·Cancer Research ·Masahisa Jinushi, Shigeki Chiba, Muhammad Baghdadi, Ichiro Kinoshita, Hirotoshi Dosaka‐Akita, Koyu Ito, Hironori Yoshiyama, Hideo Yagita∥, Toshimitsu Uede, Akinori Takaoka	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact